1	Italian	_	JJ	_	_	5	NMOD	_	_
2	chemical	_	NN	_	_	5	NMOD	_	_
3	giant	_	NN	_	_	5	NMOD	_	_
4	Montedison	_	NNP	_	_	5	NAME	_	_
5	S.p.A.	_	NNP	_	_	15	SBJ	_	_
6	,	_	,	_	_	7	P	_	_
7	through	_	IN	_	_	15	PRN	_	_
8	its	_	PRP$	_	_	13	NMOD	_	_
9	Montedison	_	NNP	_	_	13	NMOD	_	_
10	Acquisition	_	NNP	_	_	13	NMOD	_	_
11	N.V.	_	NNP	_	_	13	NMOD	_	_
12	indirect	_	JJ	_	_	13	NMOD	_	_
13	unit	_	NN	_	_	7	PMOD	_	_
14	,	_	,	_	_	7	P	_	_
15	began	_	VBD	_	_	0	ROOT	_	_
16	its	_	PRP$	_	_	20	NMOD	_	_
17	$	_	$	_	_	20	NMOD	_	_
18	37-a-share	_	JJ	_	_	17	AMOD	_	_
19	tender	_	NN	_	_	20	NMOD	_	_
20	offer	_	NN	_	_	15	OBJ	_	_
21	for	_	IN	_	_	20	NMOD	_	_
22	all	_	DT	_	_	25	NMOD	_	_
23	the	_	DT	_	_	25	NMOD	_	_
24	common	_	JJ	_	_	25	NMOD	_	_
25	shares	_	NNS	_	_	21	PMOD	_	_
26	outstanding	_	JJ	_	_	25	APPO	_	_
27	of	_	IN	_	_	25	NMOD	_	_
28	Erbamont	_	NNP	_	_	27	PMOD	_	_
29	N.V.	_	NNP	_	_	28	POSTHON	_	_
30	,	_	,	_	_	28	P	_	_
31	a	_	DT	_	_	32	NMOD	_	_
32	maker	_	NN	_	_	28	APPO	_	_
33	of	_	IN	_	_	32	NMOD	_	_
34	pharmaceuticals	_	NNS	_	_	33	PMOD	_	_
35	incorporated	_	VBN	_	_	32	APPO	_	_
36	in	_	IN	_	_	35	LOC	_	_
37	the	_	DT	_	_	38	NMOD	_	_
38	Netherlands	_	NNPS	_	_	36	PMOD	_	_
39	.	_	.	_	_	15	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	offer	_	NN	_	_	15	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	advertised	_	VBN	_	_	2	APPO	_	_
5	in	_	IN	_	_	4	LOC	_	_
6	today	_	NN	_	_	8	NMOD	_	_
7	's	_	POS	_	_	6	SUFFIX	_	_
8	editions	_	NNS	_	_	5	PMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	The	_	DT	_	_	13	NMOD	_	_
11	Wall	_	NNP	_	_	13	NAME	_	_
12	Street	_	NNP	_	_	13	NAME	_	_
13	Journal	_	NNP	_	_	9	PMOD	_	_
14	,	_	,	_	_	2	P	_	_
15	is	_	VBZ	_	_	0	ROOT	_	_
16	scheduled	_	VBN	_	_	15	VC	_	_
17	to	_	TO	_	_	16	OPRD	_	_
18	expire	_	VB	_	_	17	IM	_	_
19	at	_	IN	_	_	18	TMP	_	_
20	the	_	DT	_	_	21	NMOD	_	_
21	end	_	NN	_	_	19	PMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	November	_	NNP	_	_	22	PMOD	_	_
24	.	_	.	_	_	15	P	_	_

1	Montedison	_	NN	_	_	3	SBJ	_	_
2	currently	_	RB	_	_	3	TMP	_	_
3	owns	_	VBZ	_	_	0	ROOT	_	_
4	about	_	IN	_	_	5	DEP	_	_
5	72	_	CD	_	_	6	NMOD	_	_
6	%	_	NN	_	_	3	OBJ	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	Erbamont	_	NN	_	_	11	NMOD	_	_
9	's	_	POS	_	_	8	SUFFIX	_	_
10	common	_	JJ	_	_	11	NMOD	_	_
11	shares	_	NNS	_	_	7	PMOD	_	_
12	outstanding	_	JJ	_	_	11	APPO	_	_
13	.	_	.	_	_	3	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	offer	_	NN	_	_	3	SBJ	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	being	_	VBG	_	_	3	VC	_	_
5	launched	_	VBN	_	_	4	VC	_	_
6	pursuant	_	JJ	_	_	5	MNR	_	_
7	to	_	TO	_	_	6	AMOD	_	_
8	a	_	DT	_	_	11	NMOD	_	_
9	previously	_	RB	_	_	11	NMOD	_	_
10	announced	_	VBN	_	_	9	AMOD	_	_
11	agreement	_	NN	_	_	7	PMOD	_	_
12	between	_	IN	_	_	11	LOC	_	_
13	the	_	DT	_	_	14	NMOD	_	_
14	companies	_	NNS	_	_	12	PMOD	_	_
15	.	_	.	_	_	3	P	_	_

